Sexuality and Menopause

By the year 2030, an estimated 1.2 billion women worldwide will be post-menopausal, underscoring a rapidly growing patient population requiring specialized care. This milestone is preceded by perimenopause, a five- to seven-year period marked by the gradual decline of estrogen, progesterone, and androgens. During this transition, patients frequently experience a cascade of symptoms, including irregular menstrual patterns, vasomotor symptoms (VMS) such as hot flashes, and genitourinary syndrome of menopause (GSM). Notably, the hormonal declines associated with menopause have profound consequences on female sexuality, leading to significant increases in sexual dysfunction as patients age. This accredited CE activity will focus on common postmenopausal sexual dysfunctions and their management.

Target Audience

This activity was designed for physicians, nurse practitioners, physician associates, nurses, pharmacists, and dietitians.

Learning Objectives

Summarize the physiologic and hormonal foundations of menopause.
Identify common sexual dysfunctions and concerns experienced by postmenopausal women.
Describe appropriate assessment of sexual function and therapeutic interventions and management strategies for sexual dysfunctions in postmenopausal women.
Evaluate the impact of perimenopausal and post-menopausal transitions on female sexual health by recognizing the increasing prevalence rates of sexual difficulties and disorders as patients age.

Commercial Support

There is no commercial support.

Course summary

Available credit:

1.00 AANP Contact Hours
Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners^® (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and . AKH Inc., Advancing Knowledge in Healthcare is accredited by AANP as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 1.00 contact hour(s) (which includes 0.00 hour(s) of pharmacology).
1.00 AAPA Category 1 CME
Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
1.00 ACPE Pharmacist
Pharmacists
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1.00 contact hours.
1.00 AMA PRA Category 1 Credit™
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
1.00 ANCC Contact Hours
Nurses
Credit being awarded: 1.00 ANCC contact hours
1.00 APA CE
Psychologists
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibly for the content of the programs.
1.00 CDR
Dietitians
1.00 AMA PRA Category 1 Credit™ Non-MD
Non-Physicians Seeking AMA Credit
AKH Inc., Advancing Knowledge in Healthcare designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™.

Course opens:

10/09/2026

Course expires:

10/09/2028

Cost:

$19.95

Rating:

All of the relevant financial relationships listed for these individuals have been mitigated.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

Committee Member, Planner, Staff(s)